(PharmaNewsWire.Com, December 15, 2017 ) Browse 142 market data Tables and 29 Figures spread through 166 Pages and in-depth TOC on "Stoma/Ostomy Care Market"
Early buyers will receive 10% customization on this report.
The report analyzes and studies the major drivers, restraints, opportunities, and challenges of the Ostomy Care Market in North America, Europe, Asia, and the Rest of the World (RoW).
The high incidence of bladder/colorectal cancer/inflammatory bowel disease; rising geriatric population; growing number of awareness programs to educate patients regarding the use of ostomy products; technological advancements in ostomy products; and efficient reimbursement system in developed countries are factors driving the growth of the ostomy market.
Based on product, the ostomy care bags segment is estimated to be the largest segment of the market in 2017.
On the basis of product type, the ostomy care market is segmented into ostomy care bags and ostomy care accessories. In 2017, the ostomy care bags segment is estimated to account for the largest share of the ostomy care market. The increasing number of patients suffering from IBD, colorectal cancer, and bladder cancer— among other diseases requiring ostomies is expected to drive this market.
Based on surgery type, the ileostomy segment expected to register the fastest growth rate in the forecast period
On the basis of surgery type, the ostomy care market is segmented into – ileostomy, colostomy, and urostomy. The ileostomy segment is expected to grow at the highest CAGR during the forecast period.
Europe to account for the largest share of the ostomy care market in 2017
Geographically, the ostomy care market is segmented into North America, Europe, Asia, and the Rest of the World. Europe is estimated to account for the largest share of the market in 2017, owing to the fact that European countries have a higher prevalence of IBD which is results in a higher number of ostomy surgeries.
The major players in the ostomy care market are ConvaTec (UK), Coloplast (Denmark), Hollister Incorporated (US), B. Braun (Germany), Alcare (Japan), Nu-Hope (US), Marlen (US), Welland Medical (UK), BAO-Health (China), Flexicare Medical (UK), Cymed (US), Schena Ostomy (US), Perma-Type (US), 3M (US), and Smith & Nephew (UK).
MarketsandMarkets™ provides quantified B2B research on 30,000 high growth niche opportunities/threats which will impact 70% to 80% of worldwide companies’ revenues. Currently servicing 5000 customers worldwide including 80% of global Fortune 1000 companies as clients. Almost 75,000 top officers across eight industries worldwide approach MarketsandMarkets™ for their painpoints around revenues decisions.
Our 850 fulltime analyst and SMEs at MarketsandMarkets™ are tracking global high growth markets following the "Growth Engagement Model – GEM". The GEM aims at proactive collaboration with the clients to identify new opportunities, identify most important customers, write "Attack, avoid and defend" strategies, identify sources of incremental revenues for both the company and its competitors. MarketsandMarkets™ now coming up with 1,500 MicroQuadrants (Positioning top players across leaders, emerging companies, innovators, strategic players) annually in high growth emerging segments. MarketsandMarkets™ is determined to benefit more than 10,000 companies this year for their revenue planning and help them take their innovations/disruptions early to the market by providing them research ahead of the curve.
MarketsandMarkets’s flagship competitive intelligence and market research platform, "RT" connects over 200,000 markets and entire value chains for deeper understanding of the unmet insights along with market sizing and forecasts of niche markets.
We are pleased to offer you this exciting, new, and entirely free professional resource. Visit our Free Biotechnology & Pharmaceuticals resource center today to browse our selection of 600+ complimentary Biotechnology & Pharmaceuticals magazines, white papers, webinars, podcasts, and more. Get popular titles including:
